⚕️ Educational information only — not medical advice. Read the full disclaimer

Anti-CCP vs Rheumatoid Factor: What a Positive Test Really Means

If a doctor suspects rheumatoid arthritis (RA), two antibody blood tests are almost always ordered: rheumatoid factor (RF) and anti-CCP (anti-cyclic citrullinated peptide, also called ACPA). A result flagged "positive" can be frightening, and a "negative" one can be falsely reassuring. This page explains what each antibody is, how accurate each test is side by side, what seropositive and seronegative RA mean for the future, the many reasons RF can be positive without RA, what a positive anti-CCP means if your joints ache but are not swollen, how low and high levels are scored, and the research linking anti-CCP to the lungs and gums. Most of all, it explains why a positive antibody test is not a diagnosis.

Important: This page is general educational information, not medical advice. RF and anti-CCP results must be interpreted by a qualified clinician together with your symptoms, a joint examination and other tests. Reference ranges and units differ between laboratories. Never start, stop or change a medication because of an antibody result without speaking to your doctor or pharmacist.

Key takeaways

  • RF is an antibody against your own IgG antibodies; anti-CCP detects antibodies against citrullinated proteins. They are different antibodies that often travel together in RA. Strong
  • Both are positive in about two-thirds of people with RA, but anti-CCP is more specific (about 95% vs 85%), so a positive anti-CCP points much more strongly toward RA.1 Strong
  • RF is often positive without RA: in Sjögren's disease, hepatitis C, other chronic infections and autoimmune diseases, and some healthy people. In one hospital study only about 1 in 4 positive RF results belonged to someone with RA.4 Strong
  • Anti-CCP can appear years before RA. In people with joint pain who test positive, roughly a quarter to a half develop arthritis within a few years, with the highest risk when RF is also positive or levels are high.141617 Strong
  • About one-third of people with RA are negative for each test. Seronegative RA is real and needs the same prompt care. Strong
  • Smoking, and possibly gum disease and lung inflammation, may help trigger anti-CCP through citrullination at mucosal surfaces.2125 Strong (smoking) / Emerging (gums, lungs)

What RF and anti-CCP actually are Strong

Both tests look for autoantibodies, antibodies that react with the body's own molecules. They target completely different things, which is why they behave differently in practice.

Rheumatoid factor (RF): an antibody against antibodies

Rheumatoid factors are antibodies directed against the Fc region (the "tail") of immunoglobulin G (IgG), the most common antibody in the blood. Routine laboratory tests mostly measure the IgM form, although IgG and IgA RF also exist. RF was first detected in RA patients in the 1940s, but it is also found in other autoimmune and non-autoimmune conditions, and in healthy people.2 Results are usually reported in international units per millilitre (IU/mL). See the glossary entry for rheumatoid factor.

Anti-CCP (ACPA): antibodies against citrullinated proteins

Citrullination is a chemical change in which enzymes called peptidylarginine deiminases (PADs) convert the amino acid arginine into citrulline inside a protein. It happens normally during inflammation and cell death. In some people, the immune system starts treating citrullinated proteins as foreign and makes anti-citrullinated protein antibodies (ACPA). Because natural citrullinated proteins vary, laboratories use a synthetic, ring-shaped ("cyclic") citrullinated peptide to capture these antibodies, hence anti-CCP. Most labs today use second-generation (CCP2) assays and report results in units per millilitre (U/mL). See the glossary entries for anti-CCP and citrullination.

Mechanism: why anti-CCP is more specific

RF is a fairly general by-product of immune activation. Anything that keeps the immune system busy for a long time, such as a chronic infection or another autoimmune disease, can push RF up. ACPA reflect a narrower loss of tolerance to citrullinated self-proteins that is strongly tied to RA and its main genetic risk factor, the HLA-DRB1 "shared epitope." Smoking and these genes interact specifically for ACPA-positive RA, not ACPA-negative RA.21 That is why a positive anti-CCP carries more weight than a positive RF.

~95%specificity of anti-CCP for RA (pooled, 37 studies)
~85%specificity of IgM RF for RA (pooled, 50 studies)
~1 in 3people with RA test negative on each antibody
4.5 yrsmedian time antibodies appeared before symptoms in blood donors

Anti-CCP vs RF: side-by-side comparison Strong

The best summary of diagnostic accuracy is a 2007 meta-analysis in Annals of Internal Medicine that pooled 37 studies of anti-CCP and 50 of RF.1 The same figures are used across our biomarkers, RA and RA vs OA pages.

Anti-CCP compared with rheumatoid factor
FeatureAnti-CCP (ACPA)Rheumatoid factor (IgM RF)
What it detectsAntibodies to citrullinated proteinsAntibodies to the Fc region of IgG2
Sensitivity for RA (pooled)About 67% (95% CI 62–72%)1About 69% (95% CI 65–73%)1
Specificity for RA (pooled)About 95% (95% CI 94–97%)1About 85% (95% CI 82–88%)1
Positive likelihood ratioAbout 12.5: a positive result raises the odds of RA substantially1About 4.9: a positive result raises the odds more modestly1
Negative likelihood ratioAbout 0.361About 0.381
In early RAResults from studies of early RA were similar to those of all studies1
PrognosisThree of four studies found a higher risk of X-ray progression with anti-CCP than with RF1Less predictive of X-ray progression than anti-CCP in most studies that compared them1
Common in other conditions?Uncommon; seen in a minority of people with psoriatic arthritis and rarely in hepatitis C1013Yes: Sjögren's disease, hepatitis C, chronic infections, other autoimmune diseases, some healthy people2
Appears before symptoms?Yes, often years earlier78Yes, often years earlier7
2010 ACR/EULAR criteriaScored together as "serology": 0, 2 or 3 of 10 points3

Put simply, the two tests catch about the same share of people with RA, but anti-CCP produces far fewer false alarms. Because each misses about a third of cases and they do not miss exactly the same people, rheumatology guidance recommends measuring both together, particularly in early arthritis.2

Reading the four result combinations

The table below is a general guide only. What a result means for you depends heavily on whether you have swollen joints, how long symptoms have lasted, your age and your other health conditions.

What each RF / anti-CCP combination usually suggests
RFAnti-CCPUsual interpretationEvidence
PositivePositiveWith swollen joints, strongly supports RA. Without arthritis, carries the highest risk of developing it, especially if levels are high.141718Strong
NegativePositiveStill highly specific for RA, or for a raised future risk in someone with joint pain. A small minority of people with psoriatic arthritis are anti-CCP positive.13Strong
PositiveNegativeLeast specific pattern. Can be RA, but other causes (Sjögren's, hepatitis C, infections, other autoimmune disease, chance) need to be considered. In people with joint pain, RF alone was not a significant predictor of arthritis in one cohort.14Strong
NegativeNegativeDoes not rule out RA (seronegative RA), psoriatic arthritis, gout or other inflammatory arthritis. Diagnosis then relies on examination, inflammation markers and imaging.Strong

Seropositive vs seronegative RA and prognosis Strong

Seropositive RA means RF and/or anti-CCP is positive; seronegative RA means both are negative. Researchers increasingly think of ACPA-positive and ACPA-negative RA as partly different diseases, with different genetic and environmental risk factors.921

In a Leiden cohort of 454 people with newly diagnosed RA, half anti-CCP positive and half negative, the two groups looked the same at first: similar morning stiffness, joint pattern, joint counts and CRP. Over four years, however, the anti-CCP-positive group had more swollen joints and more severe X-ray joint damage.9 This fits the meta-analysis finding that anti-CCP predicts erosive disease better than RF.1

Seronegative does not mean "mild" or "not real." People with seronegative RA can have just as many swollen joints at diagnosis and still need prompt treatment. Being seropositive is a reason for closer monitoring, not a prediction of how your own disease will go. Modern treat-to-target care has changed outcomes for both groups. See why early treatment matters and how disease activity is tracked.

What else causes a positive RF Strong

Because RF is a general marker of immune activation, a positive result has many possible explanations. A U.S. teaching-hospital analysis of RF tests ordered in everyday practice found a positive predictive value for RA of only 24%: most positive results were in people who did not have RA.4 The test is most useful when a clinician already has a moderate suspicion of RA from the examination.

Conditions associated with a positive rheumatoid factor
ConditionWhat the evidence showsEvidence
Sjögren's diseaseRF was positive in 48.6% of 10,500 people with primary Sjögren's at diagnosis in an international registry.12 Dry eyes and mouth can also occur in RA, so the overlap can be confusing.Strong
Hepatitis CIn 147 people with hepatitis C, RF was positive in 54% of those with joint pain and 27% of those without; anti-CCP was positive in only 2 people.10 In a smaller Italian study, no hepatitis C patient was anti-CCP positive.11 Hepatitis C can cause joint pain that mimics RA, which is where anti-CCP helps tell them apart.Strong
Other chronic infectionsLong-lasting infections that keep the immune system activated can raise RF.2Strong
Other autoimmune diseasesRF can occur in lupus, mixed cryoglobulinemia and other connective-tissue diseases.2 In the Copenhagen study, rising RF levels were also linked with most other autoimmune rheumatic diseases.5Strong
Healthy peopleRF occurs in some healthy people.2 In 2,138 control samples from Dutch blood donors, 1.1% were IgM-RF positive.7Strong
Older ageRF is traditionally described as more common in older adults, but the evidence is mixed: in 9,712 Danish adults, RF levels were similar from age 20 to 100,5 and the U.S. hospital study found false-positive RF was not significantly more frequent in the elderly.4Contested
Psoriatic arthritisUsually RF negative; a negative RF actually counts toward the CASPAR criteria for psoriatic arthritis.Strong

But RF is not meaningless in healthy people

The Copenhagen City Heart Study followed 9,712 adults without RA for nearly three decades. Compared with an RF below 25 IU/mL, the risk of later RA was about 3.6 times higher at 25–50 IU/mL, 6 times higher at 50–100 IU/mL and 26 times higher above 100 IU/mL. The highest absolute 10-year risk, 32%, was in women aged 50–69 who smoked and had RF above 100 IU/mL.5 These are relative risks, and the highest absolute risk applied to one specific group, so a high RF is a reason for awareness and follow-up, not alarm.

A positive anti-CCP without RA Strong

Anti-CCP is highly specific, but it is not perfect, and it can show up long before RA does. Two different situations need to be kept apart: a positive test in someone with no symptoms, and a positive test in someone with joint pain but no swollen joints.

In the general population

In the Dutch Lifelines study of 40,136 adults, 1.0% tested anti-CCP positive. Only 22% of those positive people had RA; in the rest, positivity was linked with older age, female sex, smoking and joint complaints.6 Testing anti-CCP in people with no joint symptoms is generally not advised outside research settings.

The pre-clinical window

Stored blood from people who later developed RA shows the antibodies often come first. In Dutch blood donors, 49% of future RA patients were positive for RF and/or anti-CCP before any symptoms, a median of 4.5 years earlier.7 In northern Sweden, 34% had anti-CCP a median of 2.5 years before symptoms, and anti-CCP had the highest predictive value of the antibodies tested.8 Our RA page describes this "pre-RA" phase.

If you have joint pain but no swollen joints

This is the most common real-world question. Several cohorts have followed seropositive people with arthralgia (joint pain without clinical swelling):

Progression to arthritis in antibody-positive people with joint pain
StudyWho was followedWhat happened
Amsterdam, 201014147 people positive for ACPA and/or IgM-RF29 developed arthritis over a median 28 months; 90% of them were ACPA positive. ACPA raised risk about 6-fold; RF alone did not significantly. Among ACPA-positive people, also having RF tripled risk.
Amsterdam, 201315374 seropositive people35% developed arthritis after a median 12 months
Leeds, 201516100 anti-CCP-positive people with new non-specific joint symptoms50% developed inflammatory arthritis (median 7.9 months). Risk was 0% with none of four features, 31% with one or two, and 62% with three or more.
Amsterdam, 202517617 seropositive people, up to 5 years34% developed arthritis. High ACPA levels (about 4.7-fold) and double positivity (about 6.8-fold) carried the highest risk compared with RF only or low ACPA.
Meta-analysis, 20261826 studiesAutoantibodies raised RA risk 3- to 19-fold. 12-month risk was highest, about 35%, in CCP2-positive people with joint pain and IgM-RF.

Features that pushed risk up across studies included morning stiffness of an hour or more, symptoms for less than a year, intermittent symptoms, a first-degree relative with RA, patient-reported joint swelling, tenderness of hand or foot joints, and inflammation on ultrasound.151617 In 2025, EULAR and ACR published joint risk stratification criteria for people with arthralgia, built on 2,293 at-risk individuals, using morning stiffness, reported joint swelling, difficulty making a fist, CRP, RF and anti-CCP. They are designed mainly to group people for prevention trials, not as a self-test.19

Can RA be prevented in high-risk people? Emerging

In the APIPPRA trial, 213 adults positive for both ACPA and RF, with inflammatory joint pain, were randomly assigned to a year of abatacept (a biologic drug) or placebo. During treatment, 6% vs 29% developed arthritis; at two years the figures were 25% vs 37%, and some benefits faded after treatment stopped.20 This is research, not standard care. If you are anti-CCP positive with joint pain, ask a rheumatologist whether monitoring or a clinical trial is appropriate for you.

Low vs high titre: how levels are scored Strong

The number matters, not only "positive" or "negative." The 2010 ACR/EULAR classification criteria score RF and anti-CCP together in a serology domain worth up to 3 of the 10 points; 6 or more classifies definite RA in someone with at least one swollen joint not better explained by another disease.3 See how RA is diagnosed for all four domains.

Serology scoring in the 2010 ACR/EULAR RA classification criteria
ResultDefinitionPoints
NegativeBoth RF and anti-CCP at or below the lab's upper limit of normal (ULN)0
Low-positiveRF or anti-CCP above the ULN but no more than 3× the ULN2
High-positiveRF or anti-CCP more than 3× the ULN3
Worked example: if your lab's upper limit for anti-CCP is 20 U/mL, a result of 45 U/mL is low-positive and a result above 60 U/mL is high-positive. Cut-offs and units differ between assays and laboratories, so a "17" at one lab cannot be compared directly with a "17" at another. Always read your number against the reference range printed on your own report.

Higher levels also carry more predictive weight in people without arthritis. High ACPA levels and double positivity were the strongest antibody predictors in the Amsterdam arthralgia cohorts, and RF above 100 IU/mL carried far higher long-term risk than borderline values in the Copenhagen population.51417 A borderline result just above the cut-off is the kind most likely to be a false positive, and some clinicians will repeat it.

Anti-CCP, the lungs and the gums Emerging

If anti-CCP appears years before the joints are involved, where is it made? The leading idea is that RA autoimmunity often starts at a mucosal surface where inflammation creates citrullinated proteins. This is covered in depth in the mucosal origins section of our RA page.

Lungs and smoking

  • Past smoking was dose-dependently linked to anti-CCP in RA. Smoking plus two copies of shared-epitope genes raised the risk of RA 21-fold, and citrullinated proteins were found in lung-lavage cells from smokers but not non-smokers.21 Strong
  • On CT scans, 76% of antibody-positive people without arthritis had airway abnormalities, compared with 33% of antibody-negative controls.22
  • RA-related antibodies were found in the sputum of 65% of seropositive at-risk people, and in some at-risk people whose blood tests were negative, suggesting local production in the lung.23

Gums and P. gingivalis

  • The gum bacterium Porphyromonas gingivalis has its own PAD enzyme and was unique among the oral pathogens tested in citrullinating proteins, including human fibrinogen and α-enolase.24
  • In 2,807 people with early RA, antibodies to a citrullinated P. gingivalis peptide were found in 11% vs 2% of controls, mainly in anti-CCP-positive patients, and antibodies from gum tissue cross-reacted with human citrullinated peptides.25
  • Gum disease and RA share risk factors such as smoking, so association is not proof of cause.

The lung and gum findings are biologically plausible and consistent across several groups, but they come largely from observational and laboratory studies. No trial has shown that treating gum disease or lung inflammation makes anti-CCP disappear or prevents RA.

Why a positive test isn't a diagnosis Strong

RA is a clinical diagnosis made by a clinician who finds inflamed (swollen) joints and rules out other causes. Antibody tests change the probability; they do not settle the question.

  • Pre-test probability matters. The same positive RF means much more in someone with symmetrical swollen hand joints than in someone tested "just in case." That is why RF had a positive predictive value of only 24% in routine hospital testing.4
  • The criteria need a swollen joint. The 2010 ACR/EULAR criteria only apply to people with confirmed synovitis in at least one joint. Even a high-positive result alone scores just 3 of the 6 points needed.3
  • Many positive people never develop RA. Most anti-CCP-positive adults in the Lifelines study did not have RA, and many seropositive people with joint pain stayed arthritis-free over years of follow-up.617
  • Negative results don't exclude RA. About a third of people with RA are negative for each test.1 Inflammation markers can also be normal; see why normal CRP and ESR don't rule out arthritis.
  • Other diseases look similar. Psoriatic arthritis, hepatitis C arthropathy, Sjögren's, lupus, viral arthritis, gout and hand osteoarthritis can all be confused with RA. Our RA vs OA guide covers the most common mix-up.

What you can influence: a balanced view

Holistic practitioners sometimes frame a positive antibody test as a call to address root causes such as smoking, gum health, gut health and inflammation. Parts of that are well supported; others are not.

Lifestyle factors and RA antibodies
FactorWhat the evidence showsEvidence
Not smokingSmoking is the clearest environmental trigger for anti-CCP-positive RA,21 and the highest absolute RA risk in Copenhagen was in RF-positive women who smoked.5 Stopping is worthwhile for many health reasons; see RA risk factors.Strong
Gum healthPlausible citrullination link via P. gingivalis; regular dental care is sensible, but there is no proof it lowers antibodies or prevents RA.2425Emerging
Diet, supplements, gut protocolsNo diet or supplement has been shown to lower anti-CCP or RF, or to stop seropositive people progressing to RA. See leaky gut and anti-inflammatory plan for what is known.Contested
"Optimizing" antibody levelsRF and anti-CCP are diagnostic and risk markers, not targets to chase. Disease activity is tracked with joint counts and CRP/ESR, not repeat antibody tests.Strong
Dietary & supplement note: Statements here about foods and dietary supplements have not been evaluated by the U.S. Food and Drug Administration (FDA) and are not intended to diagnose, treat, cure, or prevent any disease.

Questions to ask your doctor

These questions can help you understand an RF or anti-CCP result:

  • Was it RF, anti-CCP, or both? If only one was done, should the other be checked?
  • What was the actual number, the lab's upper limit of normal, and is it low-positive or high-positive (more than 3× the limit)?
  • Do you find any swollen joints on examination, and would ultrasound help?
  • What are my CRP and ESR? (See CRP vs ESR.)
  • Could something else explain a positive RF, such as Sjögren's, hepatitis C, another infection or another autoimmune condition? Should I be tested for those?
  • If I am positive but have no arthritis, what is my risk, what symptoms should make me come back sooner, and how often should I be reviewed?
  • Should I be referred to a rheumatologist or an early-arthritis or at-risk clinic, or considered for a research study?
  • If I am seronegative but my joints are swollen, what else could it be, and what are the next steps?

Our guide to using biomarkers with your doctor and the flare tracker can help you bring a clear symptom history to the appointment.

When to see a doctor Strong

Seek same-day or emergency care if you have:
  • a hot, red, swollen joint with fever, chills or feeling generally unwell, which can be septic arthritis (see gout red flags);
  • new shortness of breath, a persistent cough or chest pain alongside joint symptoms;
  • a painful, red eye or sudden change in vision;
  • new weakness, numbness or tingling in the hands or feet, or a rash with purple spots that do not fade when pressed.

Book a prompt appointment, and ask about referral to a rheumatologist, if you have joints that stay swollen for more than a few weeks, morning stiffness lasting more than 30 minutes, pain when squeezing across the knuckles or the balls of the feet, or a positive anti-CCP with ongoing joint symptoms, whatever your RF result. Early treatment of RA protects joints; see the RA red flags.

Frequently asked questions

What is the difference between anti-CCP and rheumatoid factor?

Rheumatoid factor (RF) is an antibody, usually of the IgM class, that targets the tail (Fc) region of the body's own IgG antibodies. Anti-CCP tests detect antibodies against citrullinated proteins (ACPA), proteins in which the amino acid arginine has been chemically converted to citrulline. In a meta-analysis of 37 anti-CCP and 50 RF studies, both were positive in about two-thirds of people with rheumatoid arthritis, but anti-CCP was more specific (about 95% versus 85%), so a positive anti-CCP points more strongly toward RA. This is educational information, not medical advice.

Can you have a positive anti-CCP and not have rheumatoid arthritis?

Yes. In a Dutch population study of 40,136 people, about 1% tested anti-CCP positive and most of them did not have RA. Anti-CCP can also appear years before RA starts. In people with joint pain but no swollen joints, studies following anti-CCP-positive patients found that roughly a quarter to a half developed arthritis over the following few years, with the risk highest when RF was also positive or anti-CCP levels were high. A rheumatologist can assess individual risk.

What does a positive rheumatoid factor mean if anti-CCP is negative?

On its own it often means very little. RF can be positive in Sjögren's disease, hepatitis C and other chronic infections, other autoimmune conditions and some healthy people. In one hospital analysis only about a quarter of positive RF results were in people with RA. A positive RF with a negative anti-CCP is still worth discussing with a doctor, especially if you have swollen joints, because some people with RA are RF positive only.

Can you have rheumatoid arthritis with negative RF and anti-CCP?

Yes. Anti-CCP is negative in roughly a third of people with RA and RF misses a similar share. Seronegative RA is diagnosed from the pattern of swollen joints, morning stiffness, inflammation markers and sometimes ultrasound or MRI. Negative antibody tests should never be a reason to ignore joints that stay swollen for weeks.

What is a high anti-CCP or RF level?

In the 2010 ACR/EULAR classification criteria, a result above the laboratory's upper limit of normal but no more than three times that limit is low-positive and scores 2 points; a result more than three times the upper limit is high-positive and scores 3 points. Units and cut-offs vary between laboratories, so the number only makes sense next to your lab's reference range. Higher anti-CCP levels have been linked to a higher chance of developing arthritis in people with joint pain.

References

  1. Nishimura K, Sugiyama D, Kogata Y, et al. Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis. Ann Intern Med. 2007;146(11):797–808. PubMed 17548411
  2. Ingegnoli F, Castelli R, Gualtierotti R. Rheumatoid factors: clinical applications. Dis Markers. 2013;35(6):727–734. PubMed 24324289
  3. Aletaha D, Neogi T, Silman AJ, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010;62(9):2569–2581. PubMed 20872595
  4. Shmerling RH, Delbanco TL. How useful is the rheumatoid factor? An analysis of sensitivity, specificity, and predictive value. Arch Intern Med. 1992;152(12):2417–2420. PubMed 1456851
  5. Nielsen SF, Bojesen SE, Schnohr P, Nordestgaard BG. Elevated rheumatoid factor and long term risk of rheumatoid arthritis: a prospective cohort study. BMJ. 2012;345:e5244. PubMed 22956589
  6. van Zanten A, Arends S, Roozendaal C, et al. Presence of anticitrullinated protein antibodies in a large population-based cohort from the Netherlands. Ann Rheum Dis. 2017;76(7):1184–1190. PubMed 28043998
  7. Nielen MM, van Schaardenburg D, Reesink HW, et al. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum. 2004;50(2):380–386. PubMed 14872479
  8. Rantapää-Dahlqvist S, de Jong BA, Berglin E, et al. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum. 2003;48(10):2741–2749. PubMed 14558078
  9. van der Helm-van Mil AH, Verpoort KN, Breedveld FC, Toes RE, Huizinga TW. Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis. Arthritis Res Ther. 2005;7(5):R949–R958. PubMed 16207336
  10. Sène D, Ghillani-Dalbin P, Limal N, et al. Anti-cyclic citrullinated peptide antibodies in hepatitis C virus associated rheumatological manifestations and Sjögren's syndrome. Ann Rheum Dis. 2006;65(3):394–397. PubMed 16474032
  11. Bombardieri M, Alessandri C, Labbadia G, et al. Role of anti-cyclic citrullinated peptide antibodies in discriminating patients with rheumatoid arthritis from patients with chronic hepatitis C infection-associated polyarticular involvement. Arthritis Res Ther. 2004;6(2):R137–R141. PubMed 15059277
  12. Brito-Zerón P, Acar-Denizli N, Ng WF, et al. How immunological profile drives clinical phenotype of primary Sjögren's syndrome at diagnosis: analysis of 10,500 patients (Sjögren Big Data Project). Clin Exp Rheumatol. 2018;36 Suppl 112(3):102–112. PubMed 30156539
  13. Kim KY, Lee YH. Anti-cyclic citrullinated peptide antibody in psoriatic arthritis: a meta-analysis of its frequency and association with clinical features. Z Rheumatol. 2020;79(4):397–403. PubMed 31286191
  14. Bos WH, Wolbink GJ, Boers M, et al. Arthritis development in patients with arthralgia is strongly associated with anti-citrullinated protein antibody status: a prospective cohort study. Ann Rheum Dis. 2010;69(3):490–494. PubMed 19363023
  15. van de Stadt LA, Witte BI, Bos WH, van Schaardenburg D. A prediction rule for the development of arthritis in seropositive arthralgia patients. Ann Rheum Dis. 2013;72(12):1920–1926. PubMed 23178208
  16. Rakieh C, Nam JL, Hunt L, et al. Predicting the development of clinical arthritis in anti-CCP positive individuals with non-specific musculoskeletal symptoms: a prospective observational cohort study. Ann Rheum Dis. 2015;74(9):1659–1666. PubMed 24728331
  17. Frazzei G, Landewé RBM, Wagenaar C, et al. Predictors of arthritis development in individuals at risk of rheumatoid arthritis: a 5-year follow-up study from a large cohort. Ann Rheum Dis. 2025;84(4):547–553. PubMed 39956700
  18. Qureshi S, Adas M, Cope PJ, et al. Autoantibodies as predictors of progression to rheumatoid arthritis: a systematic review and meta-analysis. RMD Open. 2026;12(1):e006368. PubMed 41672721
  19. van Steenbergen HW, Doornkamp F, Alivernini S, et al. EULAR/ACR risk stratification criteria for development of rheumatoid arthritis in the risk stage of arthralgia. Ann Rheum Dis. 2025;84(9):1445–1457. PubMed 40447498
  20. Cope AP, Jasenecova M, Vasconcelos JC, et al. Abatacept in individuals at high risk of rheumatoid arthritis (APIPPRA): a randomised, double-blind, multicentre, parallel, placebo-controlled, phase 2b clinical trial. Lancet. 2024;403(10429):838–849. PubMed 38364839
  21. Klareskog L, Stolt P, Lundberg K, et al. A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum. 2006;54(1):38–46. PubMed 16385494
  22. Demoruelle MK, Weisman MH, Simonian PL, et al. Airways abnormalities and rheumatoid arthritis-related autoantibodies in subjects without arthritis: early injury or initiating site of autoimmunity? Arthritis Rheum. 2012;64(6):1756–1761. PubMed 22183986
  23. Willis VC, Demoruelle MK, Derber LA, et al. Sputum autoantibodies in patients with established rheumatoid arthritis and subjects at risk of future clinically apparent disease. Arthritis Rheum. 2013;65(10):2545–2554. PubMed 23817979
  24. Wegner N, Wait R, Sroka A, et al. Peptidylarginine deiminase from Porphyromonas gingivalis citrullinates human fibrinogen and α-enolase: implications for autoimmunity in rheumatoid arthritis. Arthritis Rheum. 2010;62(9):2662–2672. PubMed 20506214
  25. Sherina N, de Vries C, Kharlamova N, et al. Antibodies to a citrullinated Porphyromonas gingivalis epitope are increased in early rheumatoid arthritis, and can be produced by gingival tissue B cells: implications for a bacterial origin in RA etiology. Front Immunol. 2022;13:804822. PubMed 35514991